Caspase-1 inhibitor targeting liver and application thereof
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ARMY MEDICAL UNIV
- Publication Date
- 2014-03-19
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biomedicine, and relates to an enzyme inhibitor and its application in the field of medicine. Background technique
[0002] Chronic liver injury mainly caused by chronic hepatitis is a major health problem in my country, and it is also one of the main causes of human death announced by the World Health Organization. Once chronic liver inflammation starts, it is difficult to stop, and further causes liver cirrhosis, liver failure, and liver cancer, which is called the "trilogy of chronic liver disease"; trauma".
[0003] Previous studies have believed that the activity of the virus in the liver is an important reason for the persistence of intrahepatic inflammation, so antiviral therapy is currently the most commonly used method for the treatment of chronic hepatitis B. However, studies have found that even if the virus replication is effectively inhibited, it is difficult to stop the malignant course of chronic h...